Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04669743 · ClinicalTrials.gov registry record · NA
Innate Immunity in Ozone-induced Airway Inflammation in COPD
A NA study, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT04669743 is a NA study that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 72 participants.
The verdict
NCT04669743, a NA study, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States. Patients with COPD are routinely exposed to indoor and outdoor air pollution, which appears to cause escalation of their respiratory symptoms, a process called exacerbation, with resulting need to seek medical attention. This research plan proposes to evaluate the impact of lung immune cells in susceptibility to develop exacerbation through an experimental model of inhalational exposure using ambient levels of a component of air pollution (ozone) in COPD patients and longitudinal sampling of their lung immune cells.
Interventions
- OTHER Ozone exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2016-04-07 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04669743
The ClinicalTrials.gov registry entry for NCT04669743 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ozone exposure is the first listed.
NCT04669743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04669743 about?
NCT04669743 is a clinical study titled "Innate Immunity in Ozone-induced Airway Inflammation in COPD". Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States. Patients with COPD are routinely exposed to indoor and outdoor air pollution, which appears to cause escalation of their respiratory symptoms, a process called exacerbation, with resulting need to ...
What is the current status of trial NCT04669743?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2016-04-07. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT04669743?
The interventions under investigation include: Ozone exposure (OTHER).
Who is sponsoring clinical trial NCT04669743?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.